The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
COSTAR GROUP INC COM 22160N109 61,060 147,977 SH   SOLE   147,977 0 0
LPL FINANCIAL HOLDINGS INC COM 50212V100 13,608 208,401 SH   SOLE   208,401 0 0
NANTKWEST INC COM 63016Q102 1,703 556,453 SH   SOLE   556,453 0 0
SORRENTO THERAPEUTICS INC COM NEW 83587F202 2,994 415,765 SH   SOLE   415,765 0 0
SABINE ROYALTY TRUST UNIT BEN INT 785688102 13,574 289,963 SH   SOLE   289,963 0 0
PLAYA HOTELS & RESORTS NV SHS N70544106 3,240 300,000 SH   SOLE   300,000 0 0
DAVE & BUSTER'S ENTERTAINMEN COM 238337109 5,712 120,000 SH   SOLE   120,000 0 0
APPFOLIO INC COM CL A 03783C100 3,508 57,372 SH   SOLE   57,372 0 0
EDITAS MEDICINE INC COM 28106W103 6,652 185,668 SH   SOLE   185,668 0 0
COUPA SOFTWARE INC COM 22266L106 999 16,056 SH   SOLE   16,056 0 0
SIENNA BIOPHARMACEUTICALS IN COM 82622H108 4,490 295,613 SH   SOLE   295,613 0 0
NANTHEALTH INC COM 630104107 392 118,503 SH   SOLE   118,503 0 0
UROGEN PHARMA LTD COM M96088105 8,994 180,746 SH   SOLE   180,746 0 0
July 18 Puts on VXX US PUT 06746L952 0 9,200 SH Put SOLE   9,200 0 0
UROGEN PHARMA LTD COM M96088105 3,519 70,713 SH   DFND   70,713 0 0
NANTHEALTH INC COM 630104107 271 81,870 SH   DFND   81,870 0 0
July 18 Puts on VXX US PUT 06746L952 1 46,000 SH Put DFND   46,000 0 0
July 18 Puts on AMLP US PUT 00162Q956 2 465,000 SH Put DFND   465,000 0 0
July 18 Calls on TLT US CALL 464287902 1 115,200 SH Call DFND   115,200 0 0